142 related articles for article (PubMed ID: 22753743)
21. Design and synthesis of stable, water soluble radicals as potential anti-cancer agents.
Lattmann E; Begum A; Plater MJ
Drug Des Discov; 1999 Nov; 16(3):195-201. PubMed ID: 10624565
[TBL] [Abstract][Full Text] [Related]
22. Regioselective synthesis of polycyclic aza-oxa and aza-oxa-thia heteroarenes as Colo-205 and HepG2 carcinoma cells growth inhibitors.
Maurya HK; Gautam SK; Pratap R; Tandon VK; Kumar A; Kumar B; Saxena S; Tripathi D; Rajwanshi M; Das M; Ram VJ
Eur J Med Chem; 2014 Jun; 81():367-77. PubMed ID: 24858542
[TBL] [Abstract][Full Text] [Related]
23. Transcription-inhibition and antitumor activities of N-alkylated tetraazacyclododecanes.
Xiong XQ; Liang F; Yang L; Wang XL; Zhou X; Zheng CY; Cao XP
Chem Biodivers; 2007 Dec; 4(12):2791-7. PubMed ID: 18081089
[TBL] [Abstract][Full Text] [Related]
24. Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.
Wang J; Ge R; Qiu X; Xu X; Wei L; Li Z; Bian J
Eur J Med Chem; 2017 Nov; 140():421-434. PubMed ID: 28987604
[TBL] [Abstract][Full Text] [Related]
25. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
Bouchikhi F; Anizon F; Moreau P
Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
Bouchikhi F; Anizon F; Moreau P
Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
[TBL] [Abstract][Full Text] [Related]
28. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
29. Organocatalytic enantioselective formal arylation of azlactones using quinones as the aromatic partner.
Li G; Sun W; Li J; Jia F; Hong L; Wang R
Chem Commun (Camb); 2015 Jun; 51(56):11280-2. PubMed ID: 26083993
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
[TBL] [Abstract][Full Text] [Related]
31. Facile synthesis of new 4-aza-podophyllotoxin analogs via microwave-assisted multi-component reactions and evaluation of their cytotoxic activity.
Shi F; Zeng XN; Zhang G; Ma N; Jiang B; Tu S
Bioorg Med Chem Lett; 2011 Dec; 21(23):7119-23. PubMed ID: 22004717
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, cytotoxicity, and QSAR study of new aza-cyclopenta[b]fluorene-1,9-dione derivatives.
Miri R; Firuzi O; Peymani P; Zamani M; Mehdipour AR; Heydari Z; Farahani MM; Shafiee A
Chem Biol Drug Des; 2012 Jan; 79(1):68-75. PubMed ID: 21838761
[TBL] [Abstract][Full Text] [Related]
34. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
35. Flavanones inhibit the clonogenicity of HCT116 cololectal cancer cells.
Woo Y; Shin SY; Hyun J; Lee SD; Lee YH; Lim Y
Int J Mol Med; 2012 Mar; 29(3):403-8. PubMed ID: 22160193
[TBL] [Abstract][Full Text] [Related]
36. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
Bourguet CB; Boulay PL; Claing A; Lubell WD
Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
[TBL] [Abstract][Full Text] [Related]
38. Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.
Nakano H; Saito N; Parker L; Tada Y; Abe M; Tsuganezawa K; Yokoyama S; Tanaka A; Kojima H; Okabe T; Nagano T
J Med Chem; 2012 Jun; 55(11):5151-64. PubMed ID: 22540945
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antiproliferative activity of two new heteroannelated (-)-muricatacin mimics.
Popsavin V; Srećo B; Benedeković G; Popsavin M; Francuz J; Kojić V; Bogdanović G
Bioorg Med Chem Lett; 2008 Oct; 18(19):5182-5. PubMed ID: 18790637
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative activity of new cytotoxic tri- and tetraazabenzo[3,2-a]fluorene-5,6-dione derivatives.
Leepasert T; Shahabi M; Shanab K; Schirmer E; Holzer W; Spreitzer H; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2013 Oct; 23(19):5264-6. PubMed ID: 23988351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
